Ovid Therapeutics is a company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Hosted by Amit Rakhit, MD, MBA, this is our podcast. This is Bold Medicine.
"What's it going to take? it all comes down to WHO can we get involved. We have to keep reminding ourselves it's not about problems, it's about solutions."
Chromosome 8p is a rare genetic condition with approximately 350 patients identified around the world and counting. In this week's episode Amit sits down with Bina Shah, Founder of Project 8p, innovator and leader in the rare disease community.
In 2018, Bina founded Project 8p to accelerate research with the goal of treatment for chromosome 8p heroes like her daughter Karina. Her family resides in New York City where Bina earned her B.S. in Finance & Marketing from NYU Stern Business School as well as her M.B.A. from Columbia University. She has over 15 years of experience in finance in the areas of mergers and acquisitions, private and public equity investing, real estate development, and property management.
To learn more about Chromosome 8p and Project 8p, visit: www.Project8p.org
(http://publish.blubrry.com/bdata/programs/boldmedicine/attach/Project-8p-Team-01-BINA-MANIAR-SHAH.jpg)
31 Jul 2019
Amanda Moore
Amanda Moore joins us to talk about her new role as CEO of the Angelman Syndrome Foundation and her leadership within the rare disease community.
Amanda and her family live in Indianapolis, Indiana. In 2015 Amanda and her husband, Adam, adopted twin boys, Jackson and Braden. Jackson was diagnosed with Angelman Syndrome in January of 2017 and since then Amanda has made it her mission to be an advocate for all people with Angelman Syndrome.
31 Jul 2019
Karen Utley
Karen Utley, President and co-Founder of the International Foundation for CDKL5 Research speaks with Amit about what it's like to be a leader in the rare epilepsy community, and what matters most to families affected by CDKL5 Deficiency Disorder.
What makes me hopeful are the advances in science. They are exciting. There are so many things that have happened in the 10 years that I’ve been in the rare disease world that I’m shocked myself. Also, the willingness for people to help. You can share your story with people who have no connection and they are moved by it. I believe our kids change people. - Karen Utley
28 May 2019
Home By Midnight: Bringing Smiles to People's Lives
As we enter the season of high school prom and joining community and friends to celebrate, Autism advocate and nonprofit founder Stephanie Mishler joins our podcast and talks about applying her love of hair and makeup to peers with special needs.
College student and special needs advocate Stephanie Mishler combines her passion for the beauty industry and her connection to the Autism community to make prom an inclusive experience for every student. Stephanie reminds us that everybody has a passion to share, and it's never too early to apply it to impact a community.
"Sharing my life's passion with other people has affected my life in so many ways."
www.homebymidnight.org
11 Feb 2019
Paul Melmeyer / Rare Disease Day
We're back, and there's no better time to kick off the 2019 season of BoldMedicine. February 28th is Rare Disease Day! Throughout the month of February hundreds of patient organizations from countries all over the world will hold awareness-raising activities celebrating the rare community of patients, caregivers and advocates. We're excited to have Paul Melmeyer, Director of Federal Policy at NORD join Amit to talk about rare disease policy and the tremendous impact NORD has on the community.
7 Sept 2018
Terry Jo Vetters Bichell
Terry Jo Vetters Bichell has been the Director/Scientific Officer of the Angelman Biomarkers and Outcome Measures Alliance (A-BOM) (https://www.angelmanbiomarkers.org/about-us/) since its inception in 2016. Dr. Bichell earned a PhD in neuroscience from Vanderbilt University in 2016, studying gene-environment interactions in Huntington’s disease rodent models, but she has been involved in Angelman research since 2000, when her son, Lou, was diagnosed with Angelman syndrome.
In this episode of Bold Medicine, Terry Jo talks about her role in advancing Angelman syndrome research and what matters most to families in the Angelman syndrome community.
14 Aug 2018
Becky Burdine / Bold Move
Becky Burdine impacts the rare disease community, the Angelman syndrome community and the scientific community in every way possible. Her approach is science driven and starts with the families in her community.
Dr. Burdine is parent to a child with Angelman Syndrome, and was a founding member and Chief Scientific Officer for the Foundation for Angelman Syndrome Therapeutics from 2008 until 2016. She also served on the Scientific Advisory Board for the Angelman Syndrome Foundation. Dr. Burdine is Associate Professor of Molecular Biology at Princeton University and currently serves as Chief Scientific Officer for the Pitt-Hopkins Research Foundation.
Also, in this episode we introduce BOLD MOVE, a new part of the program where Amit answers questions from the rare disease community.
11 May 2018
Global Genes
Amit speaks with Kendall James-Davis, Senior Manager of Strategic Alliances at Global Genes, about the impact of patient involvement in discovery. Kendall talks about the remarkable team of advocates at Global Genes dedicated to supporting families affected by rare, genetic disorders. www.globalgenes.org
(https://goo.gl/images/Us8Z6q)
30 Apr 2018
Sam and Alexis Maydew
Amit is joined by Sam and Alexis Maydew, parents of a child with Angelman Syndrome. The Maydew's talk about their journey as parents, advocates and leaders in the Angelman Syndrome community.
21 Mar 2018
The Cute Syndrome Foundation
Amit talks with Hillary Savoie, Founder of The Cute Syndrome Foundation. Hillary shares her journey as a parent and rare epilepsy community leader.
7 Feb 2018
Welcome to Ovid
In the first episode we introduce our host, Dr. Amit Rakhit, MD, MBA. Amit talks about the core philosophy that makes Ovid Therapeutics different in our approach. Amit also shares a remarkable story that inspires him to come to work every single day -- and it starts with the pictures hanging on the office walls at Ovid.
5 Feb 2018
Why We Do What We Do
Amit introduces Chief Scientific Officer and Founder, Matthew During, M.D., D.Sc., and core members of the Ovid Research team. Matt, Melanie, Toshiya, and Amit talk about the diverse science-driven Ovid family, and the patients who inspire them every single day.
5 Feb 2018
Lennox-Gastaut Syndrome
Founder of the Lennox-Gastaut Syndrome Foundation, Christina Sanlnocecio, talks about innovative programs available for LGS patients and families. This incredible foundation is driving science and supporting every patient and family affected by Lennox-Gastaut Syndrome.
5 Feb 2018
Chelsea Leyland
Chelsea Leyland shares her story of growing up with Juvenile Myclonic Epilepsy. Chelsea talks about her battle with rare epilepsy and the need to remove stigmas attached to the disease. In this episode we talk about what it's like to watch a loved one have a seizure, and how important early diagnosis is.
5 Feb 2018
NORD Summit and Dr. Google
A hot topic at this year's National Organization for Rare Disorders (NORD) Summit was patient access to medication. In our patient-centric quick fire challenge, Amit tells us about the perfect patient partner.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
4.7 / 5
6 ratings
Host of BoldMedicine?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
